Elmwood Wealth Management, Inc. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Elmwood Wealth Management, Inc. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$309,698
-9.4%
7,9430.0%0.14%
-5.5%
Q1 2024$341,947
-26.3%
7,943
-21.1%
0.15%
-55.1%
Q4 2023$463,779
+34.8%
10,0690.0%0.32%
+95.8%
Q3 2023$343,958
-11.3%
10,0690.0%0.17%
-8.3%
Q2 2023$387,657
-27.8%
10,069
-32.8%
0.18%
-28.7%
Q1 2023$536,636
-9.2%
14,9940.0%0.25%
-13.9%
Q4 2022$591,213
+9.3%
14,9940.0%0.30%
+9.3%
Q3 2022$541,000
+18.6%
14,9940.0%0.27%
+4.2%
Q2 2022$456,000
-0.4%
14,9940.0%0.26%
+10.2%
Q1 2022$458,000
-18.9%
14,994
-17.1%
0.24%
-12.6%
Q4 2021$565,000
+61.9%
18,080
-3.5%
0.27%
+46.2%
Q2 2021$349,000
+4.2%
18,7290.0%0.18%
-9.8%
Q1 2021$335,000
+42.6%
18,7290.0%0.20%
+6.8%
Q3 2020$235,0000.0%18,7290.0%0.19%0.0%
Q2 2020$235,000
-99.7%
18,7290.0%0.19%
+117.0%
Q1 2020$91,772,000
+37205.7%
18,7290.0%0.09%
-58.9%
Q4 2019$246,000
+45.6%
18,7290.0%0.21%
+25.1%
Q3 2019$169,000
-8.6%
18,7290.0%0.17%
+4.3%
Q2 2019$185,000
-2.6%
18,7290.0%0.16%
-6.8%
Q1 2019$190,000
+61.0%
18,7290.0%0.18%
+54.4%
Q4 2018$118,000
-100.0%
18,7290.0%0.11%
-44.4%
Q3 2018$247,223,000
-6.4%
18,729
-50.0%
0.20%
-14.6%
Q2 2018$264,078,000
+187.8%
37,458
+100.0%
0.24%
+172.7%
Q1 2018$91,772,00018,7290.09%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 3,516,851$44,101,0002.72%
Parkman Healthcare Partners LLC 590,267$7,402,0002.08%
ACUTA CAPITAL PARTNERS, LLC 517,500$6,489,0001.88%
Soleus Capital Management, L.P. 250,897$3,146,0001.79%
DAFNA Capital Management LLC 346,535$4,346,0001.25%
KNOTT DAVID M 169,000$2,119,0001.16%
Ghost Tree Capital, LLC 325,000$4,076,0001.08%
Avoro Capital Advisors LLC 2,800,000$35,112,0000.69%
NEA Management Company, LLC 992,107$12,441,0000.50%
Orbimed Advisors 2,497,917$31,324,0000.44%
View complete list of XENON PHARMACEUTICALS INC shareholders